| 4/14/2010 | BKHY | Moody's reviews Axcan
|
| 3/27/2009 | BKHY | Moody's lifts Axcan to SLG-1
|
| 2/18/2009 | HY | S&P upgrades Axcan
|
| 12/31/2008 | BKHY | Axcan buyout financing to include $475 million credit facility, $275 million bonds
|
| 9/17/2008 | HY | S&P rates Axcan B+
|
| 5/1/2008 | HY | Market Commentary: Range Resources prices deal; Amkor, Visteon continue rising; funds see $297 million inflow
|
| 4/30/2008 | HY | New Issue: Axcan prices $235 million 123/4% eight-year senior notes at 98.84 to yield 13%
|
| 4/30/2008 | HY | Market Commentary: Axcan Pharma prices eight-year deal, then moves up; Visteon leads auto parts names higher; Six Flags flies
|
| 4/29/2008 | HY | Axcan Pharma sets price talk for $235 million eight-year notes at 13% area
|
| 4/29/2008 | HY | Market Commentary: Macrovision prices five-year; new Ford Credit notes firm smartly; Univision gains on Televisa trial delay
|
| 4/28/2008 | HY | Axcan Pharma revives $235 million offering of eight-year senior notes
|
| 4/28/2008 | HY | Market Commentary: Ford Credit sells giant deal, parent up on Tracinda news; MarkWest adds on; Cott off as results disappoint
|
| 2/22/2008 | BKHY | Moody's rates Axcan loans, notes Ba2
|
| 2/22/2008 | HY | Market Commentary: CHC Helicopter flies on takeover news; Mobile Mini dives; little impact from GMAC/ResCap downgrade
|
| 2/15/2008 | HY | Market Commentary: Junk easier in pre-holiday trade; builders steady before downgrade; Nuveen easier on monoline turmoil
|
| 2/14/2008 | HY | Market Commentary: Goodman sells private deal; Goodyear up on good numbers; GMAC off on warning; funds add $3 million
|
| 2/13/2008 | HY | New Issue: Axcan prices $228 million 91/4% secured notes, abandons $235 million unsecured note offering
|
| 2/13/2008 | HY | Market Commentary: Axcan Pharma prices a tranche; Hawker Beechcraft, Amkor gain on numbers; Idearc bounces back
|
| 2/12/2008 | HY | Axcan Pharma sets talk for restructured $460 million two-part note offering
|
| 2/12/2008 | HY | Market Commentary: Levi Strauss better on earnings; GM mixed in active dealings after numbers; Idearc finds a bottom
|
| 2/11/2008 | HY | Market Commentary: Directory names continue slide amid generally heavy market; casinos off; GM up ahead of quarterly results
|
| 2/11/2008 | HY | Axcan Pharma upsizes bonds to $460 million, replaces term loan B with secured notes tranche
|
| 2/11/2008 | HY | Market Commentary: Directory names continue slide amid generally heavy market; casinos off; GM up ahead of quarterly results
|
| 2/8/2008 | HY | Market Commentary: Idearc, other directory bonds slide again; Freescale off as CEO exits; funds see $142 million inflow
|
| 2/5/2008 | HY | Market Commentary: Junk market ends off, but no rout; builders up as Standard Pacific gains; casinos a losing bet
|
| 2/4/2008 | HY | Market Commentary: Football hangover stills trading; acquisitive Freescale gyrates; builders, retailers gain; Solutia eases terms
|
| 2/1/2008 | HY | Market Commentary: Petroleum Development deal prices; Freescale continues rebound; junk market generally firmer
|
| 1/31/2008 | HY | Axcan to start roadshow Friday for $240 million eight-year senior notes
|
| 1/31/2008 | HY | Market Commentary: Freescale firmer after numbers; Ford Credit gets clocked; retailers recover; funds see $78 million outflow
|
| 1/31/2008 | HY | Market Commentary: Freescale firmer after numbers; Ford Credit gets clocked; retailers recover; funds see $78 million outflow
|
| 1/25/2008 | BKCVHY | Moody's rates Axcan loans Ba2, notes B3
|
| 1/24/2008 | BKHY | S&P rates Axcan loans BB-, notes B-
|
| 1/24/2008 | HY | Axcan Pharma's $275 million eight-year notes to come via Banc of America
|
